Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F] FDHT PET/MRI in Localized Prostate Cancer
NCT02297386Phase 1Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Nov 2014
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Increase in Standardized Uptake Values (SUV) at 1 year. Started Nov 2014; status: completed.
Beyond the preview
Go deeper on NCT02297386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02297386.